Jacobs Levy Equity Management, Inc Akebia Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $23.9 Billion
  • Q3 2025

A detailed history of Jacobs Levy Equity Management, Inc transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 662,530 shares of AKBA stock, worth $1.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
662,530
Previous 1,205,128 45.02%
Holding current value
$1.13 Million
Previous $4.39 Million 59.23%
% of portfolio
0.01%
Previous 0.02%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 17, 2025
SELL
$2.7 - $4.01 $1.47 Million - $2.18 Million
-542,598 Reduced 45.02%
662,530 $1.79 Million
Q2 2025

Aug 14, 2025
SELL
$1.55 - $3.97 $580,051 - $1.49 Million
-374,227 Reduced 23.69%
1,205,128 $4.39 Million
Q1 2025

May 15, 2025
BUY
$1.69 - $2.84 $592,590 - $995,831
350,645 Added 28.54%
1,579,355 $3.03 Million
Q4 2024

Feb 14, 2025
SELL
$1.26 - $2.13 $1.01 Million - $1.72 Million
-805,459 Reduced 39.6%
1,228,710 $2.29 Million
Q3 2024

Nov 14, 2024
SELL
$0.94 - $1.55 $56,930 - $93,874
-60,564 Reduced 2.89%
2,034,169 $2.69 Million
Q2 2024

Aug 14, 2024
BUY
$0.86 - $1.63 $393,153 - $745,162
457,155 Added 27.92%
2,094,733 $2.14 Million
Q1 2024

May 15, 2024
SELL
$1.27 - $2.24 $278,570 - $491,337
-219,347 Reduced 11.81%
1,637,578 $3 Million
Q4 2023

Feb 14, 2024
BUY
$0.8 - $1.28 $110,291 - $176,465
137,864 Added 8.02%
1,856,925 $2.3 Million
Q3 2023

Nov 16, 2023
BUY
$0.87 - $1.84 $324,535 - $686,373
373,029 Added 27.71%
1,719,061 $1.96 Million
Q2 2023

Aug 14, 2023
BUY
$0.51 - $1.43 $75,127 - $210,650
147,308 Added 12.29%
1,346,032 $1.24 Million
Q1 2023

May 15, 2023
SELL
$0.56 - $1.15 $456,984 - $938,449
-816,043 Reduced 40.5%
1,198,724 $671,000
Q4 2022

Feb 14, 2023
SELL
$0.25 - $0.58 $7,012 - $16,268
-28,049 Reduced 1.37%
2,014,767 $1.17 Million
Q3 2022

Nov 15, 2022
BUY
$0.3 - $0.46 $379,559 - $581,991
1,265,199 Added 162.7%
2,042,816 $646,000
Q2 2022

Aug 15, 2022
SELL
$0.32 - $0.67 $66,279 - $138,773
-207,124 Reduced 21.03%
777,617 $275,000
Q1 2022

May 16, 2022
SELL
$0.72 - $2.93 $1.26 Million - $5.14 Million
-1,753,159 Reduced 64.03%
984,741 $707,000
Q4 2021

Feb 14, 2022
BUY
$2.26 - $3.34 $171,432 - $253,355
75,855 Added 2.85%
2,737,900 $6.19 Million
Q3 2021

Nov 15, 2021
SELL
$2.35 - $3.88 $576,429 - $951,721
-245,289 Reduced 8.44%
2,662,045 $7.67 Million
Q2 2021

Aug 16, 2021
BUY
$2.83 - $4.2 $677,233 - $1.01 Million
239,305 Added 8.97%
2,907,334 $11 Million
Q1 2021

May 17, 2021
BUY
$2.92 - $5.06 $1.97 Million - $3.41 Million
673,177 Added 33.75%
2,668,029 $9.03 Million
Q4 2020

Feb 16, 2021
BUY
$2.22 - $3.78 $2.88 Million - $4.9 Million
1,296,947 Added 185.83%
1,994,852 $5.59 Million
Q3 2020

Nov 16, 2020
BUY
$2.39 - $13.08 $551,521 - $3.02 Million
230,762 Added 49.4%
697,905 $1.75 Million
Q2 2020

Aug 17, 2020
SELL
$6.67 - $13.58 $204,202 - $415,751
-30,615 Reduced 6.15%
467,143 $6.34 Million
Q1 2020

May 15, 2020
BUY
$4.1 - $10.24 $558,112 - $1.39 Million
136,125 Added 37.64%
497,758 $3.77 Million
Q4 2019

Feb 14, 2020
BUY
$3.16 - $6.73 $1.14 Million - $2.43 Million
361,633 New
361,633 $2.29 Million
Q3 2019

Nov 14, 2019
SELL
$3.55 - $5.4 $541,236 - $823,289
-152,461 Closed
0 $0
Q2 2019

Aug 13, 2019
SELL
$4.1 - $8.05 $1.99 Million - $3.91 Million
-485,099 Reduced 76.09%
152,461 $738,000
Q1 2019

May 14, 2019
BUY
$5.41 - $8.73 $1.2 Million - $1.94 Million
222,708 Added 53.68%
637,560 $5.22 Million
Q4 2018

Feb 14, 2019
BUY
$5.39 - $9.15 $454,916 - $772,260
84,400 Added 25.54%
414,852 $2.29 Million
Q3 2018

Nov 14, 2018
BUY
$7.44 - $10.65 $403,984 - $578,284
54,299 Added 19.66%
330,452 $2.92 Million
Q2 2018

Aug 14, 2018
BUY
$9.15 - $11.34 $1.76 Million - $2.19 Million
192,834 Added 231.44%
276,153 $2.76 Million
Q1 2018

May 15, 2018
BUY
$9.53 - $15.68 $447,042 - $735,533
46,909 Added 128.84%
83,319 $794,000
Q4 2017

Feb 13, 2018
BUY
$14.24 - $19.59 $208,188 - $286,405
14,620 Added 67.09%
36,410 $541,000
Q3 2017

Nov 14, 2017
BUY
$13.06 - $19.67 $30,168 - $45,437
2,310 Added 11.86%
21,790 $429,000
Q2 2017

Nov 09, 2017
BUY
N/A
19,480
19,480 $280,000

Others Institutions Holding AKBA

# of Institutions
189
Shares Held
121M
Call Options Held
267K
Put Options Held
280K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $313M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email